Laxmi Dental Limited Q2 FY26 Concall Decoded: 26% Growth, Scanner Addiction, and the Quiet March Toward Digital Dental Monopoly
1. Opening Hook
While most midcap companies are busy blaming “macro uncertainty” for average numbers, Laxmi Dental casually dropped its strongest-ever quarter—again.
Yes, scanners dented margins, US tariffs pinched profits, and competition is apparently everywhere. Yet revenues marched on, EBITDA stayed upright, and PAT quietly flexed with a 45% YoY jump.
Management sounded less like they were defending turf and more like they were patiently watching smaller players exhaust themselves.
Between scanners infiltrating clinics, labs scaling globally, and pediatric dentistry waiting for regulatory green lights, this isn’t a one-quarter wonder.
Stick around. The scanner strategy everyone is questioning might just be the moat nobody else can afford.
2. At a Glance
Revenue ₹72 Cr (+26.5%) – Second strongest quarter in company history, no festival boost needed.
EBITDA Margin 15.3% – Scanners ate margins, but future scale is being fed.
PAT ₹8.5 Cr (+44.7%) – Profits quietly outpaced revenue growth.
Zero Debt – CFO slept well this quarter.
Cash ₹93.7 Cr – IPO money still stretching its legs.
Scanners +95% YoY – Digital dentistry is no longer optional.
3. Management’s Key Commentary
“This is our strongest ever quarterly sale for the second time in a row.” (Translation: This isn’t a fluke anymore.) 😏
“Margins were impacted due to scanner sales and US tariffs.” (Translation: Strategic pain, not structural damage.)
“We exceeded FY25 scanner sales in H1 itself.” (Translation: Dentists are officially converting.)
“International lab business grew 39% despite tariffs.” (Translation: Geography diversification is working.)
“We are India’s only branded dental lab.” (Translation: Price wars are for the unbranded.)
“CE certification for Kids-E expected in Q4.” (Translation: Pediatric growth switch about to flip.)
4. Numbers Decoded
Source table
Metric
Q2 FY26
Decoded Reality
Revenue
₹72.3 Cr
Growth across labs, aligners, scanners
EBITDA
₹11 Cr
Scanner-heavy mix diluted margins
EBITDA Margin
15.3%
Temporary dip, not new normal
PAT
₹8.5 Cr
Operating leverage kicking in
H1 EBITDA Margin
16.6%
H2 historically stronger
Cash Balance
₹93.7 Cr
Balance sheet very comfortable
One-liner: Growth first, margins later—and the company is honest about it.
